BioSpace News Archive

Fact.MR – A Market Research and Competitive Intelligence Provider: The global microdermabrasion devices market is projected to exhibit growth at a CAGR of 4% between 2020-2030.

Diverticular is one of the foremost common gastrointestinal conditions affecting the overall population in the world.

Nivolumab is a targeted therapy drug and the generic name of Opdivo. Currently, nivolumab has received approval for various indications such as unresectable or metastatic melanoma, metastatic non-small cell lung cancer (NSCLC), advanced renal cell cancer, classical Hodgkin’s lymphoma (cHL), and recurrent or metastatic squamous cell carcinoma.